A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral ...

Discover a study that found that young adults had the highest UV exposure and sunburn rates, and were least likely to use ...

A once-daily oral therapy targeting neutrophilic inflammation has shown promise in reducing exacerbations in patients with ...

A phase 3 clinical trial reports that nerandomilast was associated with a smaller decline in forced vital capacity in ...

Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...

A 2024 nationwide survey of French ICUs reveals critical gaps in managing invasive candidiasis, including underutilization of ...

Presented at EuroPCR 2025, the 10-year results of the DANAMI-3-PRIMULTI trial show how complete revascularisation cuts ...

Discover a Phase 3 trial that evaluated stapokibart as an additional therapy for adults with moderate-to-severe seasonal ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

In people living with HIV, gut microbiome differences linked to antiretroviral therapy and weight gain are small compared to ...

New research, from COMy 2025, has found that specific senescence-associated biomarkers are significantly correlated with ...

Discover a study about an AI model named PLAN-B-DF that has been developed to improve the prediction of hepatocellular ...